Avidity Biosciences Insider Sold Shares Worth $831,605, According to a Recent SEC Filing

MT NewswiresDec 19 05:53

PepGen Stock Craters 35% on FDA Clinical Hold

Seeking AlphaDec 16 22:56

Avidity Biosciences (RNA) Receives a Buy From TD Cowen

TipRanksDec 13 12:25 · Ratings

Avidity Biosciences: Advancing Clinical Programs With Strategic Focus and Growth Potential

TipRanksNov 27 13:36

Dyne, Avidity Initiated at Outperform by RBC on DM1 Drugs

Seeking AlphaNov 27 02:03

Avidity Biosciences to Participate in Upcoming Investor Conference

PR NewswireNov 26 23:00